Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: Prediction of clinical status - Is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice?

C. Hengstenberg; J. Erdmann; P. Charron

doi:10.1016/S0008-6363(02)00781-2

Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: Prediction of clinical status - Is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice?

C. Hengstenberg^*, J. Erdmann, P. Charron

^*Corresponding author for this work

Institute of Cardiogenetics

4 Citations (Scopus)

Original language	English
Journal	Cardiovascular Research
Volume	57
Issue number	2
Pages (from-to)	298-301
Number of pages	4
ISSN	0008-6363
DOIs	https://doi.org/10.1016/S0008-6363(02)00781-2
Publication status	Published - 01.02.2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being
SDG 5 Gender Equality

Research Areas and Centers

Research Area: Medical Genetics

Access to Document

10.1016/S0008-6363(02)00781-2

Cite this

Hengstenberg, C., Erdmann, J., & Charron, P. (2003). Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: Prediction of clinical status - Is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice? Cardiovascular Research, 57(2), 298-301. https://doi.org/10.1016/S0008-6363(02)00781-2

Hengstenberg, C. ; Erdmann, J. ; Charron, P. / Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: Prediction of clinical status - Is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice?. In: Cardiovascular Research. 2003 ; Vol. 57, No. 2. pp. 298-301.

@article{0d713ad0801444058f3709be9d5bcf14,

title = "Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: Prediction of clinical status - Is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice?",

author = "C. Hengstenberg and J. Erdmann and P. Charron",

year = "2003",

month = feb,

day = "1",

doi = "10.1016/S0008-6363(02)00781-2",

language = "English",

volume = "57",

pages = "298--301",

journal = "Cardiovascular Research",

issn = "0008-6363",

publisher = "Oxford University Press",

number = "2",

}

Hengstenberg, C, Erdmann, J & Charron, P 2003, 'Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: Prediction of clinical status - Is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice?', Cardiovascular Research, vol. 57, no. 2, pp. 298-301. https://doi.org/10.1016/S0008-6363(02)00781-2

Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: Prediction of clinical status - Is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice? / Hengstenberg, C.; Erdmann, J.; Charron, P.
In: Cardiovascular Research, Vol. 57, No. 2, 01.02.2003, p. 298-301.

Research output: Journal Articles › Editorial

TY - JOUR

T1 - Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: Prediction of clinical status - Is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice?

AU - Hengstenberg, C.

AU - Erdmann, J.

AU - Charron, P.

PY - 2003/2/1

Y1 - 2003/2/1

UR - https://www.scopus.com/pages/publications/0037304749

U2 - 10.1016/S0008-6363(02)00781-2

DO - 10.1016/S0008-6363(02)00781-2

M3 - Editorial

C2 - 12566102

AN - SCOPUS:0037304749

SN - 0008-6363

VL - 57

SP - 298

EP - 301

JO - Cardiovascular Research

JF - Cardiovascular Research

IS - 2

ER -

Hengstenberg C, Erdmann J, Charron P. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: Prediction of clinical status - Is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice? Cardiovascular Research. 2003 Feb 1;57(2):298-301. doi: 10.1016/S0008-6363(02)00781-2

Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: Prediction of clinical status - Is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice?

UN SDGs

Research Areas and Centers

Access to Document

Other files and links

Cite this